dysfunction, attentional deficits and hyperactivity, developmental delay with greater language deficits, minor craniofacial and limb anomalies, and variable growth deficiency.
Previously, three affected children, born to women who inhaled toluene regularly throughout pregnancy, have been reported. Two more cases are described emphasising the importance of toluene as a potential human teratogen.
Toluene is an aromatic hydrocarbon commonly used as a solvent or thinner in a number of industrial products.' Exposure in humans primarily occurs in an occupational setting. However, toluene is also abused recreationally through inhalation.
Evidence for teratogenicity as a result of occupational exposure to toluene prenatally has been inconclusive. In 1985, three children with microcephaly, central nervous system dysfunction, minor craniofacial and limb anomalies, and variable growth deficiency, born to women who chronically inhaled toluene throughout pregnancy, were reported.2 Two more cases of toluene embryopathy are described, further emphasising the potential for teratogenicity from chronic in utero exposure to this solvent. group.bmj.com on December 29, 2017 -Published by http://jmg.bmj.com/ Downloaded from Psychological testing at three years two months indicated a mental age of three years two months with an IQ of 86 on the Stanford-Binet Intelligence Scale, Form LM. Receptive language abilities were comparable to her mental age and she had a mild expressive language impairment and a speech articulation disorder. There were no attentional problems.
At three years two months her length was 91 cm (10th centile), weight 13-3 kg (10th centile), and OFC 47 cm (5th centile). Physical findings are listed in the table. Renal ultrasound was normal. Patient 2 (figs 2b and 3) is a white female who was evaluated because of poor weight gain. She was born at term to a 28 year old primigravida who had at least a 10 year history of regular inhalation abuse of toluene that resulted in mild ataxia, tremor, and slurred speech. During pregnancy, toluene paint reducer was sniffed almost daily. She occasionally consumed alcohol, but did not have any other substance abuse. The father was 29 years old and there was no consanguinity.
At birth, her weight was 2550 g (slightly <10th centile) and length 48 cm (slightly >25th centile). Other than expressive language delay, early developmental milestones appeared normal. She had a short attention span. Although the pathogenesis of toluene embryopathy has not been determined, we have previously suggested that alterations in brain development and facial morphogenesis may result from a deficiency in the neural plate, leading to abnormal proliferation and migration of neural crest cells.2 Altered craniofacial development occurring as a result of abnormal differentiation and migration of cephalic neural crest cells is also considered to be the pathogenic mechanism of other human teratogens, such as alcohol and retinoic acid with exposure occurring at a critical period of embryogenesis.3 These similarities emphasise the potential existence of a non-specific teratogenic phenotype with abnormal growth, development, and morphogenesis as a consequence of this disturbance. It is anticipated that variability in clinical features of patients with toluene embryopathy and absence of manifestations in others after similar prenatal exposure will result from a number of factors including the duration and intensity of exposure, nature of the preparation, interaction with other agents, and especially the genetic predisposition of the exposed fetus.5
Clinical findings in these five patients support chronic toluene exposure in utero through inhalation as a potential human teratogen. There is one other recent report of an infant described as having similar craniofacial anomalies, microcephaly, and stubby fingertips whose mother abused spray paint during pregnancy.6 The prevalence of toluene embryopathy among solvent abusers and the amount of prenatal exposure necessary to result in adverse fetal effects is yet to be determined. In addition, the impact of polydrug use on the phenotype will need to be assessed, although presumably this did not represent a confounding issue in our patients, since substance abuse was primarily limited to toluene inhalation. It is anticipated that continued evaluation of physical characteristics, growth, and development of infants exposed to toluene in utero should help to answer these questions. 
